Literature DB >> 9346467

Wernicke's encephalopathy: an excitotoxicity hypothesis.

W J McEntee.   

Abstract

Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346467

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  2 in total

Review 1.  Conversion of upbeat to downbeat nystagmus in Wernicke encephalopathy.

Authors:  Jorge C Kattah; Ali Saber Tehrani; Sascha du Lac; David E Newman-Toker; David S Zee
Journal:  Neurology       Date:  2018-10-23       Impact factor: 9.910

2.  Nonalcoholic Wernicke's Encephalopathy Associated with Unintentional Weight Loss, Cholecystectomy, and Intractable Vomiting: The Role of Dual Thiamine and Corticosteroid Therapy.

Authors:  Vivek Verma; Chenell Donadee; Leslie Gomez; Marina Zaretskaya
Journal:  Case Rep Neurol Med       Date:  2014-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.